Cite

MLA Citation

    Elizabeth Hohmann et al.. “19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial.” Open forum infectious diseases, vol. 8, n.d., p. S13. http://access.bl.uk/ark:/81055/vdc_100150542873.0x000021
  
Back to record